At a glance
The April 5, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on SARS-CoV-2 variants and testing, and an FDA update.
Format: MP3
Language: English (US)
Size: 20 MB
Agenda
Welcome: Nancy Anderson, CDC Division of Laboratory Systems (DLS)
Emergence of SARS-CoV-2 Variants and Impact on IVD Testing: Richard Creager, NIH RADx Variant Task Force
Saliva-Based SARS-CoV-2 Testing Data: Anne Wyllie, Yale University
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)
Content Source:
Division of Laboratory Systems